Table 7.
Comparative evaluation of TCM and positive control with regard to obesity-related metabolic diseases.
| Intervention | Research type | Subjects | Outcome | Changes in IM | Disease | Ref |
|---|---|---|---|---|---|---|
| a specifically designed herbal formula (AMC) | Clinical trial | Human | HOMA-β↑; FBG, PBG, HbA1c, HOMA-IR, TC, TG, LDL-C↓ |
Blautia, Faecalibacterium, Roseburia, Gemmiger, Coprococcus, Megamonas↑ | T2DM with hyperlipidemia | (Tong et al., 2018) |
| Metformin | HOMA-β↑; FBG, PBG, HbA1c, TC, LDL-C↓ |
Blautia↑; Alistipes, Oscillibacter, Bacteroides↓ |
||||
| Berberine | Animal experiments | Wistar rats | BW, Adiposity index↓ | Blautia, Allobaculum, Bacteriodes, Butyricoccus, Lactobacillus↑; Clostridium XlVa, Flavonifractor, Lachnospiracea_inc, Roseburia, Clostridium XI↓ |
Obesity | (Zhang et al., 2015) |
| Metformin | BW, Adiposity index↓ | Akkermensia, Prevotella, Lactobacillus, Blautia, Allobaculum, Bacteriodes, Butyricoccus↑; Clostridium XlVa, Flavonifractor, Lachnospiracea_inc, Roseburia, Clostridium XI↓ |
||||
| Scutellaria baicalensis+Metformin | Animal experiments | LETO rats | BW, FBG, TC, HOMA-ISI↓ | Lactobacillus, Bacteroides↑; Clostridium, Enterobacter↓ |
T2DM | (Han et al., 2017) |
| Metformin | BW, FBG, HOMA-ISI↓ | / | ||||
| Psyllium husk | Animal experiments | C57BL/6J mice | BW, TC, TG, LPS, LDL/HDL ratio↓ | Firmicutes, Bacteroidetes, Bilophila, Sutterella, Roseburia, Bacteroides, Faecalibacterium, Coprobacillus, Parabacteroides distasonis↑; F/B ratio↓ |
Obesity with hypercholesterolemia and NAFLD | (Deng et al., 2022) |
| Orlistat | BW, TC, TG, LPS, LDL/HDL ratio↓ | Firmicutes, Bacteroidetes, Sutterella, Akkermansia↑; F/B ratio↓ |
||||
| Polygonatum kingianum | Animal experiments | SD rats | HDL-C↑; BW, FBG, TG, LDL-C, FINS, HOMA-IR↓ |
Bacteroides, Oscillibacter, Allobaculum, Blautia, Phascolarctobacterium↑; F/B ratio, Proteobacteria, Lactobacillus, Psychrobacter↓ |
Metabolic syndrome | (Gu et al., 2020) |
| Simvastatin | HDL-C↑; BW, FBG, TG, LDL-C, FINS, HOMA-IR↓ |
Proteobacteria↑ | ||||
| Jiang-Tang-San-Huang | Animal experiments | SD rats | HDL-C↑; FBG, TBA, TNF-α, IL-6, IL-1β, TC, TG, LDL, FFA, FINS, AST, ALT, Cr, BUN↓ |
Romboutsia, Lactobacillus, Turicibacter, Bacteroides, Bifidobacterium, Clostridium-sensu stricto 1↑; F/B ratio↓ |
T2DM | (Tawulie et al., 2023) |
| metformin | FBG, TBA, TNF-α, IL-6, IL-1β, FINS↓ | / | ||||
| Fufang-zhenzhu-tiaozhi formula | Animal experiments | C57BL/6 mice | TC, TG, Scr, ACR, Urinary albumin/creatinine ratio, serum creatinine, 24h albuminuria, kidney/body weight ratio, IL-6↓ | Bacteroidetes↑; F/B ratio, Weissella, Enterococcus, Akkermansia↓ |
Diabetic kidney disease | (Lan et al., 2023) |
| Losartan | IL-6, serum creatinine, urinary albumin/creatinine ratio, 24h albuminuria, kidney/body weight ratio↓ | / | ||||
| Qijian mixture | Animal experiments | KKay mice | BW, FBG↓ | Bacteroidetes↑; Firmicutes, Actinobacteria↓ |
T2DM | (Gao et al., 2018) |
| Metformin | BW, FBG, INS↓ | Bacteroidetes, Proteobacteria↑; Firmicutes, Actinobacteria↓ |
||||
| Scrophulariae Radix and Atractylodes sinensis pair+Metformin | Animal experiments | SD rats | HDL-C↑; BW, FBG, LDL, FPG, PBG, GSP, HOMA-IR↓ |
Firmicutes, F/B ratio, Lactobacillus, Pediococcus, Clostridium, Dehalobacterium, Ruminococcu↑; Actinobacteria, Bacteroidetes, Butyricicoccus, SMB53, Prevotella↓ |
T2DM | (Guo et al., 2022) |
| Metformin | BW, FBG, LDL, FPG, GSP, HOMA-IR↓ | Butyricicoccus, SMB53, Clostridium,↑; Lactobacillus, F/B ratio, Prevotella↓ |
||||
| Xiao-Ke-Yin | Animal experiments | db/db mice | BW, FBG, ITT, insulin, HOMA-IR, ALT, AST, TC, TG, FFA, IL-6, TNF-α↓ | Bacilli, Lactobacillaceae and Lactobacillus↑; Clostridia, Lachnospircaeae, Tannerellaceae, Parabacteroides↓ |
T2DM | (Li M. et al., 2023) |
| Metformin | BW, FBG, ITT, insulin, HOMA-IR, ALT, AST, TC, TG, FFA, IL-6, TNF-α↓ | / |
BW, body weight; FPG, fasting plasma glucose; PBG, Postprandial blood glucose; HbA1c, hemoglobin A1c; TC, total cholesterol; TG, triglyceride; LDL, low-density lipoprotein cholesterol; HDL, high-density lipoprotein cholesterol; HOMA-IR, homeostasis assessment of insulin resistance; FINS, fasting insulin; FFA, free fatty acid; HOMA-ISI, homeostasis assessment of insulin sensitivity index; IL, interleukin; TNF-α, tumor necrosis factor-α; Scr, serum creatinine.
The “↑” symbol is used to indicate an increase, improvement, or positive change in a quantity.
The “↓” symbol is used to indicate a decrease, decline, or negative change.